Digital Edition

ihansen's blog

Iraq War Soldier Inspires Skincare Formulators

Submitted by ihansen on Mon, 06/27/2011 - 16:46
Main Image: 
Innovative Skincare COO Alec Call and CEO Bryan Johns with soldier Linda Lee

Skin care and the military are two terms rarely associated with each other. Yet, thanks to an unexpected request from Chief Warrant Officer-3 Linda Lee, these two worlds have collided, resulting in an innovative new product. While stationed in Iraq in 2009, Lee wrote a letter to Innovative Skincare (www.isclinical.com) requesting a recommendation for a hydrating cleanser that could remove the sweat and grime of the soldiers’ desert climate, even when they had no access to water.

Restylane Becomes First Approved Lip Filler

Submitted by ihansen on Thu, 10/13/2011 - 15:18
Main Image: 
Restylane Receives FDA Approval for Lip Augmentation

The United States Food and Drug Administration has expanded the approved usage of RESTYLANE Injectable Gel (Medicis Aesthetics) to include lip augmentation. RESTYLANE was previously approved to treat moderate to severe facial wrinkles and nasolabial folds. Its new label will include an indication for submucosal implantation for lip augmentation in patients over the age of 21. In addition, the RESTYLANE package insert will be amended to include both the new indication and results from the clinical trials for lip augmentation.

Call for Submissions

Submitted by ihansen on Fri, 09/16/2011 - 16:34

The American Society for Laser Medicine and Surgery (www.aslms.org) has put out a call for abstracts for its upcoming annual conference, Laser 2012. The conference will take place on April 18-22, 2012 at the Gaylord Palms Resort & Convention Center in Kissimmee, Florida. Physicians and researchers who would like to have their research and clinical findings considered for presentation at the meeting can submit their scientific abstracts for review at www.aslmsabstracts.org. The deadline for submissions is October 17, 2011.

FDA Seeks Public Comments on Medical Device Approvals

Submitted by ihansen on Tue, 08/02/2011 - 12:00

In September 2009, the United States Food & Drug Administration (FDA) commissioned a report from the Institute of Medicine (IOM) on the current 510(k) pre-market approval process, the most common pathway to market for lower-risk medical devices. The FDA undertook the assessment in response to concerns raised by various stakeholders in an effort to determine what, if any, changes should be made to improve the program and update it so that it adequately addresses the level of current device complexity and today’s marketplace.

Position Statement on Stem Cells Released

Submitted by ihansen on Mon, 06/27/2011 - 16:39

In response to growing media coverage and marketing claims surrounding so-called “stem cell therapies,” the American Society for Aesthetic Plastic Surgery (ASAPS) and the American Society of Plastic Surgeons (ASPS) have created a joint task force on the use of stem cells in aesthetic surgery, led by J. Peter Rubin, MD. The task force enlisted the help of researchers at the University of Pittsburgh McGowan Institute for Regenerative Medicine to review more than 2,000 published papers on the use of stem cells in plastic surgery.

Syndicate content